홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

6-Chloro-4-morpholinopyridazin-3-amine → tert-Butyl 3-(6-chloro-8-morpholinoimidazo[1,2-b]pyridazin-2-yl)azetidine-1-carboxylate

HRID 718589
인쇄

반응식

HRID 718589 반응식
Br[CH2:2][C:3]([CH:5]1[CH2:8][N:7]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:6]1)=O.[Cl:16][C:17]1[N:22]=[N:21][C:20]([NH2:23])=[C:19]([N:24]2[CH2:29][CH2:28][O:27][CH2:26][CH2:25]2)[CH:18]=1>CN(C=O)C>[Cl:16][C:17]1[CH:18]=[C:19]([N:24]2[CH2:29][CH2:28][O:27][CH2:26][CH2:25]2)[C:20]2[N:21]([CH:2]=[C:3]([CH:5]3[CH2:8][N:7]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:6]3)[N:23]=2)[N:22]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 575175366-Chloro-4-morpholinopyridazin-3-amineHCID 90357297Tert-butyl 3-(2-bromoacetyl)azetidine-1-carboxylate

생성물 1

HCID 117732465tert-Butyl 3-(6-chloro-8-morpholinoimidazo[1,2-b]pyridazin-2-yl)azetidine-1-carboxylate

시약·촉매·용매 1

HCID 6228Dimethylformamide용매2회

실험 절차

A solution of tert-butyl 3-(2-bromoacetyl)azetidine-1-carboxylate (207 mg, 0.744 mmol) in DMF (1 mL) was added to a solution of compound 19a (99.8 mg, 0.465 mmol) and Na2HPO4 (165 mg, 2.50 mmol) in DMF (20 mL). The resulting mixture was stirred at rt overnight. The reaction mixture was concentrated in vacuo and the residue obtained was purified by normal phase column chromatography on silica gel (0-100% EtOAc/heptane) to obtain compound 19b. Mass Spectrum (LCMS, ESI pos.): Calcd. for C19H25ClN4O3: 393.2 (M+H). found: 393.3.

후처리

  1. concentrationThe reaction mixture was concentrated in vacuo
  2. customthe residue obtained
  3. customwas purified by normal phase column chromatography on silica gel (0-100% EtOAc/heptane)

출처 및 근거

ORD 기록
ord-3f47937894774e39a9314f640b2a8eef
출처 데이터셋
uspto-grants-2015_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09193736B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트